Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observation of the Effects of Guideline-driven Lifestyle Interventions, Including Use of a Red-yeast Based Nutraceutical , in Subjects With Hypercholesterolemia at Low-moderate Cardiovascular Risk Not Requiring a Drug Therapy

NCT05000541 is registered in ClinicalTrials.gov with Mylan Inc. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05000541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observation of the Effects of Guideline-driven Lifestyle Interventions, Including Use of a Red-yeast Based Nutraceutical , in Subjects With Hypercholesterolemia at Low-moderate Cardiovascular Risk Not Requiring a Drug Therapy
Lead sponsor
Mylan Inc.
Phase
Observational
Overall status
Completed
Start date
December 8, 2020
Completion date
October 31, 2023
Enrollment
259 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.